2017
DOI: 10.1210/jc.2016-3503
|View full text |Cite
|
Sign up to set email alerts
|

BMP15 Mutations Associated With Primary Ovarian Insufficiency Reduce Expression, Activity, or Synergy With GDF9

Abstract: Mutations in BMP15 associated with POI reduce mature protein production, activity, or synergy with GDF9. The latter effect is perhaps most interesting given that interactions with GDF9 most likely underlie the physiology of BMP15 in the human ovary.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
19
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 27 publications
(21 citation statements)
references
References 38 publications
0
19
0
Order By: Relevance
“…In addition, abnormalities in Gdf9 and BMP15 expression are associated with polycystic ovarian syndrome (PCOS) and primary ovarian insufficiency (POI) in humans [4850]. The receptor Scarb1 was differentially expressed in DDT lineage granulosa and has been associated with POI [51].…”
Section: Discussionmentioning
confidence: 99%
“…In addition, abnormalities in Gdf9 and BMP15 expression are associated with polycystic ovarian syndrome (PCOS) and primary ovarian insufficiency (POI) in humans [4850]. The receptor Scarb1 was differentially expressed in DDT lineage granulosa and has been associated with POI [51].…”
Section: Discussionmentioning
confidence: 99%
“…In brief, COV434 cells were plated at 75,000 cells per well in 48-well plates in complete medium (DMEM supplemented with 10% fetal calf serum) at 37°C in 5% carbon dioxide. Following overnight incubation, cells were transfected with 250 ng perwell of a BMP response element–luciferase reporter (BRE-reporter as previously described [14]) using Lipofectamine 3000 (Invitrogen, Carlsbad, CA) according to the manufacturer’s instructions. At 24 hours posttransfection, the COV434 cells were treated with increasing doses of conditioned media containing the BMP7 variants for 16 hours.…”
Section: Methodsmentioning
confidence: 99%
“…At 24 hours posttransfection, the COV434 cells were treated with increasing doses of conditioned media containing the BMP7 variants for 16 hours. The medium was then aspirated, the cells were solubilized in solubilization buffer [25 mm glycylglycine (pH 7.8), 15 mm magnesium sulfate, 4 mm EGTA, 1% Triton X-100, and 1 mm dithiothreitol], and luciferase reporter activity was measured, as previously described [14]. Data were analyzed using Graphpad Prism 7 software and expressed as fold of nontreated wells (fold-control).…”
Section: Methodsmentioning
confidence: 99%
“…Transient transfection of HEK293 cells with GDF9 variants either alone or in combination with BMP15, followed by Western blotting of conditioned media and cell lysates was carried out as described previously [17]. (100 nM) was added 24 h after transfection.…”
Section: Western Blotmentioning
confidence: 99%